KillBaitOral PCSK9 Inhibitor Enlicitide Reduces LDL Cholesterol by Approximately 60% in Phase 3 Trial
📰 Original title: New pill cuts “bad” cholesterol by 60% in major trial
🤖 IA: It's clickbait ⚠️
👥 Usuarios: It's clickbait ⚠️
View full AI summary: https://killbait.com/en/oral-pcsk9-inhibitor-enlicitide-reduces-ldl-cholesterol-by-approximately-60-in-phase-3-trial/?redirpost=cee93522-b80d-43fc-aa95-396287d3e6e5
Oral PCSK9 Inhibitor Enlicitide Reduces LDL Cholesterol by Approximately 60% in Phase 3 Trial
A phase 3 clinical trial published in The New England Journal of Medicine demonstrated that enlicitide, an experimental oral PCSK9 inhibitor developed by Merck, significantly lowered low-density…